Error analysis for PET measurement of dopamine D2 receptor occupancy by antipsychotics with [11C]raclopride and [ 11C]FLB 457

NeuroImage

Volumn 42, Issue 4, 2008, Pages 1285-1294

  Ikoma, Yoko ^a,b   Ito, Hiroshi ^a   Arakawa, Ryosuke ^a   Okumura, Masaki ^a   Seki, Chie ^a   Shidahara, Miho ^a   Takahashi, Hidehiko ^a   Kimura, Yuichi ^a   Kanno, Iwao ^a   Suhara, Tetsuya ^a  

^a NATIONAL INSTITUTE OF RADIOLOGICAL SCIENCES   (Japan)

^b NATIONAL CEREBRAL AND CARDIOVASCULAR CENTER   (Japan)

Author keywords

11C FLB 457; 11C raclopride; Dopamine D2 receptor; Occupancy; Positron emission tomography

Indexed keywords

DOPAMINE 2 RECEPTOR; ISOREMOXIPRIDE; ISOREMOXIPRIDE C 11; RACLOPRIDE C 11; RISPERIDONE; SULPIRIDE; SULTOPRIDE; UNCLASSIFIED DRUG;

ADULT; ANALYTICAL ERROR; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DRUG RECEPTOR BINDING; HUMAN; HUMAN EXPERIMENT; MALE; MATHEMATICAL COMPUTING; NORMAL HUMAN; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SIMULATION; TEMPORAL CORTEX; THALAMUS;

ADULT; ANTIPSYCHOTIC AGENTS; BRAIN; CARBON RADIOISOTOPES; HUMANS; IMAGE INTERPRETATION, COMPUTER-ASSISTED; MALE; PYRROLIDINES; RACLOPRIDE; RADIOPHARMACEUTICALS; RECEPTORS, DOPAMINE D2; REPRODUCIBILITY OF RESULTS; SALICYLAMIDES; SENSITIVITY AND SPECIFICITY; TISSUE DISTRIBUTION;

EID: 55349098210     PISSN: 10538119     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuroimage.2008.05.056     Document Type: Article

References (30)

1. Agid O., Mamo D., Ginovart N., Vitcu I., Wilson A.A., and Zipursky R.B. Striatal vs extrastriatal dopamine D2 receptors in antipsychotic response-a double-blind PET study in schizophrenia Neuropsychopharmacology 32 2007 1209 1215
2. Asselin M.C., Montgomery A.J., Grasby P.M., and Hume S.P. Quantification of PET studies with the very high-affinity dopamine D2/D3 receptor ligand [11C]FLB 457: re-evaluation of the validity of using a cerebellar reference region J. Cereb. Blood Flow Metab. 27 2007 378 392
3. Delforge J., Bottlaender M., Loc'h C., Guenther I., Fuseau C., and Bendriem B. Quantitation of extrastriatal D2 receptors using a very high-affinity ligand (FLB 457) and the multi-injection approach J. Cereb. Blood Flow Metab. 19 1999 533 546
4. Farde L., and Nordstrom A.L. PET examination of central D2 dopamine receptor occupancy in relation to extrapyramidal syndromes in patients being treated with neuroleptic drugs Psychopharmacol. Ser. 10 1993 94 100
5. Farde L., Ehrin E., Eriksson L., Greitz T., Hall H., and Hedstrom C.G. Substituted benzamides as ligands for visualization of dopamine receptor binding in the human brain by positron emission tomography Proc. Natl. Acad. Sci. USA 82 1985 3863 3867
6. 2 dopamine receptor occupancy in schizophrenic patients treated with antipsychotic drugs Arch Gen Psychiatry 45 1988 71 76
7. 2 dopamine receptors in neuroleptic-naïve schizophrenic patients Arch. Gen. Psychiatry 47 1990 213 219
8. Farde L., Nordstrom A.L., Halldin C., Wiesel F.A., and Sedvall G. PET studies of dopamine receptors in relation to antipsychotic drug treatment Clin. Neuropharmacol. 15 1992 468A 469A
9. Farde L., Nordstrom A.L., Wiesel F.A., Pauli S., Halldin C., and Sedvall G. Positron emission tomographic analysis of central D1 and D2 dopamine receptor occupancy in patients treated with classical neuroleptics and clozapine. Relation to extrapyramidal side effects Arch. Gen Psychiatry 49 1992 538 544
10. 2-dopamine receptors in healthy subjects and antipsychotic drug-treated patients Psychopharmacology (Berl) 133 1997 396 404
11. Gunn R.N., Lammertsma A.A., Hume S.P., and Cunningham V.J. Parametric imaging of ligand-receptor binding in PET using a simplified reference region model Neuroimage 6 1997 279 287
12. Halldin C., Farde L., Hogberg T., Mohell N., Hall H., and Suhara T. Carbon-11-FLB 457: a radioligand for extrastriatal D2 dopamine receptors J. Nucl. Med. 36 1995 1275 1281
13. 11C]DASB positron emission tomography studies of the serotonin transporter in human brain J. Cereb. Blood Flow Metab. 23 2003 1096 1112
14. 11C]raclopride binding J. Cereb. Blood Flow Metab. 18 1998 941 950
15. Kapur S., Zipursky R., Jones C., Remington G., and Houle S. Relationship between dopamine D(2) occupancy, clinical response, and side effects: a double-blind PET study of first-episode schizophrenia Am. J. Psychiatry 157 2000 514 520
16. Kukreja S.L., and Gunn R.N. Bootstrapped DEPICT for error estimation in PET functional imaging Neuroimage 21 2004 1096 1104
17. Lammertsma A.A., and Hume S.P. Simplified reference tissue model for PET receptor studies Neuroimage 4 1996 153 158
18. Lidow M.S., Williams G.V., and Goldman-Rakic P.S. The cerebral cortex: a case for a common site of action of antipsychotics Trends Pharmacol. Sci. 19 1998 136 140
19. Logan J., Fowler J.S., Volkow N.D., Ding Y.S., Wang G.J., and Alexoff D.L. A strategy for removing the bias in the graphical analysis method J. Cereb. Blood Flow Metab. 21 2001 307 320
20. Mizrahi R., Rusjan P., Agid O., Graff A., Mamo D.C., and Zipursky R.B. Adverse subjective experience with antipsychotics and its relationship to striatal and extrastriatal D2 receptors: a PET study in schizophrenia Am. J. Psychiatry 164 2007 630 637
21. Nordstrom A.L., Farde L., Wiesel F.A., Forslund K., Pauli S., and Halldin C. Central D2-dopamine receptor occupancy in relation to antipsychotic drug effects: a double-blind PET study of schizophrenic patients Biol. Psychiatry 33 1993 227 235
22. Nyberg S., Farde L., Halldin C., Dahl M.L., and Bertilsson L. D2 dopamine receptor occupancy during low-dose treatment with haloperidol decanoate Am. J. Psychiatry 152 1995 173 178
23. Ogden R.T., and Tarpey T. Estimation in regression models with externally estimated parameters Biostatistics 7 2006 115 129
24. Ogden R.T., Ojha A., Erlandsson K., Oquendo M.A., Mann J.J., and Parsey R.V. In vivo quantification of serotonin transporters using [(11)C]DASB and positron emission tomography in humans: modeling considerations J. Cereb. Blood Flow Metab. 27 2007 205 217
25. Olsson H., and Farde L. Potentials and pitfalls using high affinity radioligands in PET and SPECT determinations on regional drug induced D2 receptor occupancy - a simulation study based on experimental data Neuroimage 14 2001 936 945
26. 11C]FLB 457 binding to extrastriatal dopamine receptors in the human brain J. Cereb. Blood Flow Metab. 19 1999 1164 1173
27. Pilowsky L.S., Mulligan R.S., Acton P.D., Ell P.J., Costa D.C., and Kerwin R.W. Limbic selectivity of clozapine Lancet 350 1997 490 491
28. Suhara T., Sudo Y., Okauchi T., Maeda J., Kawabe K., and Suzuki K. Extrastriatal dopamine D2 receptor density and affinity in the human brain measured by 3D PET Int. J. Neuropsychopharmacol. 2 1999 73 82
29. Talvik M., Nordstrom A.L., Nyberg S., Olsson H., Halldin C., and Farde L. No support for regional selectivity in clozapine-treated patients: a PET study with [(11)C]raclopride and [(11)C]FLB 457 Am. J. Psychiatry 158 2001 926 930
30. Turkheimer F., Sokoloff L., Bertoldo A., Lucignani G., Reivich M., and Jaggi J.L. Estimation of compartment and parameter distribution in spectral analysis J. Cereb. Blood Flow Metab. 18 1998 1211 1222